Horizon Enterprise Ltd Blue serves as Executive at Stoke Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Horizon Enterprise Ltd Blue has executed 2 insider transactions totaling $69.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 19, 2024 involved selling 1,937,500 shares valued at $27.2M.
Horizon Enterprise Ltd Blue currently holds 8,906,181 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Horizon Enterprise Ltd Blue has been a net seller of STOK stock. They have purchased $0 and sold $69.0M worth of shares.
Horizon Enterprise Ltd Blue's most recent insider trade was on Sep 19, 2024, when they sold 1,937,500 shares at $14.05 per share.
Get notified when new Form 4 filings are submitted
| $11.60 |
| Discretionary |